Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Beta Cell Dysfunction in Longstanding T1D

NCT03632759 is registered in ClinicalTrials.gov with Carla Greenbaum, MD as lead sponsor.

NCT NCT03632759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03632759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Beta Cell Dysfunction in Longstanding T1D
Lead sponsor
Carla Greenbaum, MD
Phase
Phase 1
Overall status
Completed
Start date
August 15, 2018
Completion date
November 9, 2021
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus